Patent applications and USPTO patent grants for MIRUM PHARMACEUTICALS, INC..The latest application filed is for "methods for treating cholestasis".
Patent | Date |
---|---|
Methods For Treating Cholestasis App 20220160726 - JAECKLIN; Thomas ;   et al. | 2022-05-26 |
Methods For Increasing Growth In Pediatric Subjects Having Cholestatic Liver Disease App 20220152022 - JAECKLIN; Thomas ;   et al. | 2022-05-19 |
Genotype And Dose-dependent Response To An Asbti In Patients With Bile Salt Export Pump Deficiency App 20220133738 - JAECKLIN; Thomas ;   et al. | 2022-05-05 |
Methods For Treating Cholestasis App 20220105092 - Jaecklin; Thomas ;   et al. | 2022-04-07 |
Methods for treating cholestasis Grant 11,229,647 - Jaecklin , et al. January 25, 2 | 2022-01-25 |
Methods For Treating Cholestasis App 20210113585 - Jaecklin; Thomas | 2021-04-22 |
Methods For Treating Cholestasis App 20200375989 - JAECKLIN; Thomas | 2020-12-03 |
SEC | 0001759425 | Mirum Pharmaceuticals, Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.